Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'Amgen'  -  Page 59
Latest

Amgen to pay $150M for misbranding Aranesp

By   /  Tuesday, December 18th, 2012  /  Latest news  /  Comments Off on Amgen to pay $150M for misbranding Aranesp

[Editor’s note: This story has been updated with comments from Amgen.] Biotech giant Amgen pleaded guilty Dec. 18 to a misdemeanor charge for misbranding its anemia drug Aranesp. According to a report from Bloomberg News, the Thousand Oaks-based firm agreed to pay $150 million in fines and penalties as part of the guilty plea. U.S. Read More →

Read More →
Latest

Amgen buys DeCode Genetics for $415M

By   /  Monday, December 10th, 2012  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen buys DeCode Genetics for $415M

Biotech giant Amgen is buying Icelandic genetics research firm DeCode Genetics for $415 million, the Thousand Oaks company said Dec. 10. The all-cash deal is expected to close before the end of the year and will give Amgen, the largest biotechnology firm in the world, opportunities to develop new medicines that target defective DNA. “DeCode Read More →

Read More →
Latest

Amgen Tour to hit Santa Barbara, Avila Beach

By   /  Tuesday, November 27th, 2012  /  Latest news, Tourism  /  Comments Off on Amgen Tour to hit Santa Barbara, Avila Beach

[Editor’s note: This story has been updated with additional information.] The Amgen Tour of California will return to Santa Barbara and visit Avila Beach for the first time ever when the Tri-Counties hosts the end of Stage 4 and all of Stage 5 for the eight-year-old road cycle racing event next year. AEG, presenter of Read More →

Read More →
Latest

Amgen aims to put cholesterol drug on market

By   /  Monday, November 19th, 2012  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen aims to put cholesterol drug on market

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen case before SCOTUS could stymie new class-action suits

By   /  Friday, November 9th, 2012  /  Columns, Law, Tri-County Public Companies  /  Comments Off on Amgen case before SCOTUS could stymie new class-action suits

On Nov. 5, Thousand Oaks-based Amgen argued a case before the U.S. Supreme Court that could make it much harder for shareholders to form a class when suing a company for making misleading statements that distort its stock price. The outcome, which is likely to be decided by the politics of the individual justices, could Read More →

Read More →
Latest

Amgen deals could foster biotech hub, panel says

By   /  Wednesday, November 7th, 2012  /  Latest news, Technology  /  Comments Off on Amgen deals could foster biotech hub, panel says

Amgen’s decision to license some of its intellectual property to a new drug company that will operate near the biotechnical giant’s Thousand Oaks headquarters could be an exciting development for biotech firms in the 101 corridor, business leaders were told at a breakfast gathering Wednesday in Westlake Village. The move could be a start toward Read More →

Read More →
Latest

Kleiner Perkins startup could spell new era for Amgen

By   /  Friday, November 2nd, 2012  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Kleiner Perkins startup could spell new era for Amgen

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →